Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review
Helicobacter pylori is recognized as the most common bacterial pathogens colonizing the gastric epithelium of nearly half of the world's population. This bacterium is the main etiological cause of gastroduodenal ulcers, and more importantly as the substantial risk factor for development of gastric cancer. The emergence and rapid increase in the prevalence of multi-drug resistant phenotypes have posed major pitfalls in effectiveness of various treatment regimens and eradication strategies against H. pylori infections. Several natural products and supplementary food components have been reported to have established anti-H. pylori activity. Herein, we review the application and efficacy of some specific natural products and foodstuffs such as milk, bee products (honey and propolis), fish oil, vitamins C and E, and also a nickel free-diet used as anti-H. pylori alternative treatment regimens.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Gastroenterology and hepatology from bed to bench - 10(2017), Suppl1 vom: 15., Seite S8-S14 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rezaeimanesh, Nasim [VerfasserIn] |
---|
Themen: |
Anti-inflammatory |
---|
Anmerkungen: |
Date Revised 13.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM281684073 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM281684073 | ||
003 | DE-627 | ||
005 | 20240313232930.0 | ||
007 | tu | ||
008 | 231225s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n1326.xml |
035 | |a (DE-627)NLM281684073 | ||
035 | |a (NLM)29511465 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rezaeimanesh, Nasim |e verfasserin |4 aut | |
245 | 1 | 0 | |a Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Revised 13.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Helicobacter pylori is recognized as the most common bacterial pathogens colonizing the gastric epithelium of nearly half of the world's population. This bacterium is the main etiological cause of gastroduodenal ulcers, and more importantly as the substantial risk factor for development of gastric cancer. The emergence and rapid increase in the prevalence of multi-drug resistant phenotypes have posed major pitfalls in effectiveness of various treatment regimens and eradication strategies against H. pylori infections. Several natural products and supplementary food components have been reported to have established anti-H. pylori activity. Herein, we review the application and efficacy of some specific natural products and foodstuffs such as milk, bee products (honey and propolis), fish oil, vitamins C and E, and also a nickel free-diet used as anti-H. pylori alternative treatment regimens | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Anti-inflammatory | |
650 | 4 | |a Dietary supplementation | |
650 | 4 | |a Drug resistance | |
650 | 4 | |a Eradication therapy | |
650 | 4 | |a Helicobacter pylori | |
700 | 1 | |a Farzi, Nastaran |e verfasserin |4 aut | |
700 | 1 | |a Pirmanesh, Samira |e verfasserin |4 aut | |
700 | 1 | |a Emami, Saeed |e verfasserin |4 aut | |
700 | 1 | |a Yadegar, Abbas |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gastroenterology and hepatology from bed to bench |d 2011 |g 10(2017), Suppl1 vom: 15., Seite S8-S14 |w (DE-627)NLM238305023 |x 2008-2258 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2017 |g number:Suppl1 |g day:15 |g pages:S8-S14 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2017 |e Suppl1 |b 15 |h S8-S14 |